 | • レポートコード：GIR-107A14582 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、グルカゴン様ペプチド-1（GLP-1）アゴニストのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。グルカゴン様ペプチド-1（GLP-1）アゴニストの種類別市場規模（エキセナチド、リラグルチド、リキシセナチド、アルビグルチド、デュラグルチド）、用途別市場規模（病院、薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・グルカゴン様ペプチド-1（GLP-1）アゴニストの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novo Nordisk、AstraZeneca、Eli Lily、GSK、Sanofi、Bristol-Myers Squibb、Amylin ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：エキセナチド、リラグルチド、リキシセナチド、アルビグルチド、デュラグルチド ・用途別分析2016年-2026年：病院、薬局、その他 ・グルカゴン様ペプチド-1（GLP-1）アゴニストの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・グルカゴン様ペプチド-1（GLP-1）アゴニストのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・グルカゴン様ペプチド-1（GLP-1）アゴニストのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・グルカゴン様ペプチド-1（GLP-1）アゴニストの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・グルカゴン様ペプチド-1（GLP-1）アゴニストの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Glucagon Like Peptide-1 (GLP-1) Agonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Glucagon Like Peptide-1 (GLP-1) Agonists size is estimated to be xx million in 2021 from USD 8007.2 million in 2020, with a change of XX% between 2020 and 2021. The global Glucagon Like Peptide-1 (GLP-1) Agonists market size is expected to grow at a CAGR of 12.7% for the next five years.
Market segmentation
Glucagon Like Peptide-1 (GLP-1) Agonists market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
Market segment by Application can be divided into
Hospital
Pharmacy
Other
The key market players for global Glucagon Like Peptide-1 (GLP-1) Agonists market are listed below:
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Glucagon Like Peptide-1 (GLP-1) Agonists product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Glucagon Like Peptide-1 (GLP-1) Agonists, with price, sales, revenue and global market share of Glucagon Like Peptide-1 (GLP-1) Agonists from 2019 to 2021.
Chapter 3, the Glucagon Like Peptide-1 (GLP-1) Agonists competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon Like Peptide-1 (GLP-1) Agonists breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Glucagon Like Peptide-1 (GLP-1) Agonists market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Glucagon Like Peptide-1 (GLP-1) Agonists sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Exenatied
1.2.3 Liraglutide
1.2.4 Lixisenatide
1.2.5 Albiglutide
1.2.6 Dulaglutide
1.3 Market Analysis by Application
1.3.1 Overview: Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size & Forecast
1.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value (2016-2026))
1.4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume (2016-2026)
1.4.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2016-2026) & (USD/Unit)
1.5 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity Analysis
1.5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Total Production Capacity (2016-2026)
1.5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Drivers
1.6.2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints
1.6.3 Glucagon Like Peptide-1 (GLP-1) Agonists Trends Analysis
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
2.1.4 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
2.2.4 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Eli Lily
2.3.1 Eli Lily Details
2.3.2 Eli Lily Major Business
2.3.3 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
2.3.4 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
2.4.4 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
2.5.4 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
2.6.4 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Amylin
2.7.1 Amylin Details
2.7.2 Amylin Major Business
2.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
2.7.4 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Manufacturer
3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Glucagon Like Peptide-1 (GLP-1) Agonists
3.4 Market Concentration Rate
3.4.1 Top 3 Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturer Market Share
3.4.2 Top 6 Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturer Market Share
3.5 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Glucagon Like Peptide-1 (GLP-1) Agonists Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Region
4.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Region (2016-2026)
4.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2016-2026)
4.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2016-2026)
4.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2016-2026)
4.4 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2016-2026)
4.5 South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2016-2026)
4.6 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Type (2016-2026)
5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2016-2026)
5.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Application (2016-2026)
6.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2016-2026)
6.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2026)
7.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2026)
7.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
7.3.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Country (2016-2026)
7.3.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2026)
8.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2026)
8.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
8.3.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Country (2016-2026)
8.3.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2026)
9.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2026)
9.3 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Region
9.3.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2026)
10.2 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2026)
10.3 South America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
10.3.1 South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Country (2016-2026)
10.3.2 South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2026)
11.2 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2026)
11.3 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
11.3.1 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Glucagon Like Peptide-1 (GLP-1) Agonists Typical Distributors
12.3 Glucagon Like Peptide-1 (GLP-1) Agonists Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type, (USD Million), 2021-2026
Table 2. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application, (USD Million), 2021-2026
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
Table 6. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
Table 10. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Eli Lily Basic Information, Manufacturing Base and Competitors
Table 12. Eli Lily Major Business
Table 13. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
Table 14. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. GSK Basic Information, Manufacturing Base and Competitors
Table 16. GSK Major Business
Table 17. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
Table 18. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
Table 22. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 24. Bristol-Myers Squibb Major Business
Table 25. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
Table 26. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Amylin Basic Information, Manufacturing Base and Competitors
Table 28. Amylin Major Business
Table 29. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product and Services
Table 30. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Manufacturer (2019-2021e) & (K Units)
Table 32. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Glucagon Like Peptide-1 (GLP-1) Agonists, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Glucagon Like Peptide-1 (GLP-1) Agonists Production Site of Key Manufacturer
Table 36. Glucagon Like Peptide-1 (GLP-1) Agonists New Entrant and Capacity Expansion Plans
Table 37. Glucagon Like Peptide-1 (GLP-1) Agonists Mergers & Acquisitions in the Past Five Years
Table 38. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2016-2021e) & (K Units)
Table 39. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2021-2026) & (K Units)
Table 40. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2016-2021e) & (USD Million)
Table 41. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2021-2026) & (USD Million)
Table 42. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2021e) & (K Units)
Table 43. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2021-2026) & (K Units)
Table 44. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2016-2021e) & (USD Million)
Table 45. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2021-2026) & (USD Million)
Table 46. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2016-2021e) & (USD/Unit)
Table 47. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2021-2026) & (USD/Unit)
Table 48. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2021e) & (K Units)
Table 49. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2021-2026) & (K Units)
Table 50. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2016-2021e) & (USD Million)
Table 51. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2021-2026) & (USD Million)
Table 52. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2016-2021e) & (USD/Unit)
Table 53. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2021-2026) & (USD/Unit)
Table 54. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2016-2021e) & (K Units)
Table 55. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2021-2026) & (K Units)
Table 56. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2016-2021e) & (USD Million)
Table 57. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2021-2026) & (USD Million)
Table 58. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2021e) & (K Units)
Table 59. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2021-2026) & (K Units)
Table 60. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2021e) & (K Units)
Table 61. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2021-2026) & (K Units)
Table 62. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2016-2021e) & (K Units)
Table 63. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2021-2026) & (K Units)
Table 64. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2016-2021e) & (USD Million)
Table 65. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2021-2026) & (USD Million)
Table 66. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2021e) & (K Units)
Table 67. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2021-2026) & (K Units)
Table 68. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2021e) & (K Units)
Table 69. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2021-2026) & (K Units)
Table 70. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2016-2021e) & (K Units)
Table 71. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2021-2026) & (K Units)
Table 72. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2016-2021e) & (USD Million)
Table 73. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2021e) & (K Units)
Table 75. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2021-2026) & (K Units)
Table 76. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2021e) & (K Units)
Table 77. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2021-2026) & (K Units)
Table 78. South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2016-2021e) & (K Units)
Table 79. South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2021-2026) & (K Units)
Table 80. South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2016-2021e) & (USD Million)
Table 81. South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2021-2026) & (USD Million)
Table 82. South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2021e) & (K Units)
Table 83. South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2021-2026) & (K Units)
Table 84. South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2021e) & (K Units)
Table 85. South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2021-2026) & (K Units)
Table 86. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2016-2021e) & (K Units)
Table 87. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2021-2026) & (K Units)
Table 88. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2016-2021e) & (USD Million)
Table 89. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2016-2021e) & (K Units)
Table 91. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2021-2026) & (K Units)
Table 92. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2016-2021e) & (K Units)
Table 93. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2021-2026) & (K Units)
Table 94. Direct Channel Pros & Cons
Table 95. Indirect Channel Pros & Cons
Table 96. Glucagon Like Peptide-1 (GLP-1) Agonists Typical Distributors
Table 97. Glucagon Like Peptide-1 (GLP-1) Agonists Typical Customers
List of Figures
Figure 1. Glucagon Like Peptide-1 (GLP-1) Agonists Picture
Figure 2. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2020
Figure 3. Exenatied
Figure 4. Liraglutide
Figure 5. Lixisenatide
Figure 6. Albiglutide
Figure 7. Dulaglutide
Figure 8. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2020
Figure 9. Hospital
Figure 10. Pharmacy
Figure 11. Other
Figure 12. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (2016-2026) & (K Units)
Figure 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2016-2026) & (USD/Unit)
Figure 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity (2016-2026) & (K Units)
Figure 17. Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Glucagon Like Peptide-1 (GLP-1) Agonists Market Drivers
Figure 19. Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints
Figure 20. Glucagon Like Peptide-1 (GLP-1) Agonists Market Trends
Figure 21. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Manufacturer in 2020
Figure 22. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Manufacturer in 2020
Figure 23. Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2016-2026)
Figure 27. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region (2016-2026)
Figure 28. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2016-2026) & (USD Million)
Figure 29. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2016-2026) & (USD Million)
Figure 31. South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2016-2026) & (USD Million)
Figure 33. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2016-2026)
Figure 34. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2016-2026)
Figure 35. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2016-2026) & (USD/Unit)
Figure 36. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2016-2026)
Figure 37. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2016-2026)
Figure 38. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2016-2026) & (USD/Unit)
Figure 39. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2016-2026)
Figure 40. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2016-2026)
Figure 41. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2016-2026)
Figure 42. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Country (2016-2026)
Figure 43. United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2016-2026)
Figure 47. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2016-2026)
Figure 48. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2016-2026)
Figure 49. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Country (2016-2026)
Figure 50. Germany Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region (2016-2026)
Figure 59. China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2016-2026)
Figure 66. South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2016-2026)
Figure 67. South America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2016-2026)
Figure 68. South America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界のペプチドAPI市場 2021：企業別、地域別、種類・用途別 The Peptide APIs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recen…- 世界のペプチドビルディングブロック市場 2021：企業別、地域別、種類・用途別 The Peptide Building Block market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界の銅ペプチド市場 2021：企業別、地域別、種類・用途別 The Copper Peptide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界の海洋性コラーゲンペプチド市場 2021：企業別、地域別、種類・用途別 The Marine Collagen Peptide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の米タンパク質ペプチド粉末市場 2021：企業別、地域別、種類・用途別 The Rice Protein Peptide Powder market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…